+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Technologist Travel Award

Association for Molecular Pathology

The AMP Technologist Travel Award provides travel assistance to the Annual Meeting & Expo for multiple selected AMP member technologists who do not receive travel support from their institutions.

Award amount: Up to $1,500 in travel reimbursement, plus meeting registration and free access to on-demand recordings after the meeting

Application opens: April 1

Application deadline: June 30

Application process

Tasks for the technologist applicant to perform:

Prepare (3) supporting documents:
1. Current CV or resume
2. Statement of Interest that includes:
  1. Description of your commitment, experience, and interest in molecular diagnostics.
  2. Description of what you expect to gain from attending the AMP Annual Meeting. For example, how you believe the knowledge gained will expand your current understanding of molecular diagnostics, how it will benefit you in their current position, and / or how it will further your career.
3. If you are an author on an abstract that is being submitted for the annual meeting, obtain a copy of the abstract in either MS Word or PDF format.
Complete and submit an online application at https://ampawards.secure-platform.com/a
Make sure that your director submits the required communication that your travel and registration for the annual meeting is not funded by your institution (see below).

Task for the technologist's lab director to perform:

Send an email to ampawards@amp.org with the following information:

Applicant's name and position
Description and amount of financial support provided by the institution:
- Registration: full, partial (amount) or none
- Airfare and/or ground transportation: full, partial (amount) or none
- Hotel: full, partial (amount) or none
- Meals: full, partial (amount) or none
Include your name and contact information

AI Based Application Success Predictor

1. Strong relevance to molecular pathology

The most competitive applications directly address:

molecular diagnostics,
genomic testing,
precision medicine,
cancer genomics,
infectious disease diagnostics,
biomarker development,
next-generation sequencing (NGS),
liquid biopsy,
laboratory medicine innovation.

Projects clearly aligned with molecular pathology practice are strongly favored.

2. Clear translational and clinical impact

AMP reviewers highly prioritize projects likely to:

improve diagnostic accuracy,
enhance personalized medicine,
optimize molecular testing workflows,
improve patient stratification,
accelerate treatment decisions,
improve laboratory quality and efficiency.

Clinical utility is one of the strongest predictors of competitiveness.

3. Strong technical and methodological rigor

Successful proposals generally demonstrate:

validated molecular methods,
robust quality controls,
reproducibility,
bioinformatics rigor,
realistic analytical pipelines,
appropriate statistical design.

Weak assay validation or poor analytic methodology is a common reviewer concern.

4. Innovation and technological advancement

Competitive applications often involve:

advanced sequencing technologies,
AI-assisted diagnostics,
novel biomarkers,
multi-omics integration,
digital pathology,
molecular automation,
precision oncology platforms.

Innovation is highly valued when clinically applicable.

5. Strong preliminary data

Applications with:

pilot sequencing data,
assay-validation results,
proof-of-concept biomarker findings,
preliminary clinical correlations,
prior publications

typically receive stronger reviewer confidence.

6. Interdisciplinary collaboration

High-scoring projects frequently involve:

molecular pathologists,
oncologists,
bioinformaticians,
geneticists,
infectious disease specialists,
laboratory scientists,
computational biologists.

Collaborative integration is highly competitive.

7. Strong publication and technical productivity

Important predictors include:

peer-reviewed publications,
technical expertise,
presentations,
laboratory innovation experience,
prior molecular diagnostics projects,
scholarly consistency.

Scientific productivity strongly influences outcomes.

8. Laboratory implementation feasibility

AMP reviewers strongly favor:

realistic clinical laboratory integration,
regulatory awareness,
scalable workflows,
CLIA/CAP-compatible processes,
operational feasibility.

Projects lacking implementation planning often score poorly.

9. Strong mentorship and institutional infrastructure

For trainees and junior investigators, reviewers assess:

mentor expertise,
molecular laboratory resources,
sequencing infrastructure,
computational support,
protected research time.

Strong institutional environments significantly improve competitiveness.

10. Potential for broader diagnostic impact

Reviewers favor projects likely to:

influence molecular testing standards,
support future NIH/federal funding,
improve precision medicine delivery,
generate multicenter collaborations,
produce clinically implementable diagnostics.

Specialties

Cell Biology

Pathology

Eligibility Requirements

The applicant must be an AMP technologist member who works in the clinical molecular diagnostics field as a technologist. "Technologist" can include clinical or R&D technologists/assistants.

Applicants may not receive funding for travel and/or registration to the Annual Meeting & Expo from their institution (communication from the lab director required).

Authorship on an abstract is preferred but not required.

Winners of the award in the previous three (3) years are not eligible.

Applicant must agree to attend the Business/Awards Session at the Annual Meeting & Expo in order to accept the award personally.

Applicant must agree to submit a 250-word report to AMP within a month of the conclusion of the 2025 AMP Annual Meeting & Expo summarizing their experiences and what they learned by attending the meeting.

Sponsor Details

Sponsor Institute/Organizations: Association for Molecular Pathology

Sponsor Type: Corporate/Non-Profit

Address: 6120 Executive Blvd., Suite 700 Rockville, MD 20852

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity